Taylor & Francis Group

SHERPA: Unknown

People

  1. Geyer
    Geyer
  2. Zelenetz
    Zelenetz
  3. Derkach
    Derkach
  4. Goldberg
    Goldberg
  5. Park
    Park
  6. Sarmasti
    Sarmasti
  7. Tallman
    Tallman
  8. Borge
    Borge
  9. Calivo
    Calivo
  10. Chin
    Chin

Groups

  1. Department of Medicine (11)
  2. Hematologic Malignancies, Division of (11)
  3. Hematology-Oncology Fellows (11)
  4. Adult Leukemia (10)
  5. Center for Hematologic Malignancies (10)
  6. Lymphoma (3)
  7. Weinberg Fellows (3)
  8. Advanced Practice Providers (2)
  9. Biostatistics Service (2)
  10. Epidemiology and Biostatistics (2)
Search Within
  1. "Lindsey Roeker"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (5)
Groups
  1. Department of Medicine (11)
  2. Hematologic Malignancies, Division of (11)
  3. Hematology-Oncology Fellows (11)
  4. Adult Leukemia (10)
  5. Center for Hematologic Malignancies (10)
  6. Lymphoma (3)

More Groups

People
  1. Lindsey Roeker (11)
  2. Anthony Mato (9)
  3. Andrew Zelenetz (3)
  4. Colleen Dorsey (3)
  5. Mark Geyer (3)
  6. Aaron Goldberg (2)

More People

Years
  1. 2025 (2)
  2. 2023 (2)
  3. 2021 (1)
  4. 2020 (6)
Publications
  1. Leukemia and Lymphoma (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Journal Article

    Shadman, M.; Salkar, M.; Srivastava, B.; Karve, S.; Emond, B.; Gogna, P.; Manceur, A. M.; Lafeuille, M. H.; Rava, A.; Sun, H.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML
    Journal Article

    Chin, K. K.; Derkach, A.; Famulare, C.; Gupta, G. K.; Borge, P. D.; Geyer, M.; Goldberg, A. D.; Haque, T.; Park, J. H.; Roeker, L. E.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Clinical outcomes among patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who received treatment with a covalent BTK and BCL2 inhibitor in the United States: A real-world database study
    Journal Article

    Eyre, T. A.; Hess, L. M.; Sugihara, T.; He, D.; Khanal, M.; Pagel, J. M.; Walgren, R. A.; Abada, P. B.; Konig, H.; Roeker, L. E.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: Identifying risk factors to help guide treatment selection
    Journal Article

    Bantilan, K. S.; Kay, N. E.; Parikh, S. A.; Rabe, K. G.; Call, T. G.; Leis, J. F.; Ding, W.; Slager, S. L.; Soumerai, J. D.; Roeker, L. E.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality
    Journal Article

    Stahl, M.; Narendra, V.; Jee, J.; Derkach, A.; Maloy, M.; Geyer, M. B.; Mato, A. R.; Roeker, L. E.; Tallman, M. S.; Shah, G. L.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • The impact of age on survival in CLL patients receiving ibrutinib as initial therapy
    Meeting Abstract

    Ujjani, C.; Mato, A.; Hill, B.; Allan, J.; Lansigan, E.; Skarbnik, A.; Jacobs, R.; Thompson, M.; Svoboda, J.; Tuncer, H. H.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Comparative analysis of targeted therapies in relapsed/refractory chronic lymphocytic leukemia (R/R CLL)
    Meeting Abstract

    Mato, A.; Roeker, L.; Eyre, T.; Ujjani, C.; Lamanna, N.; Hill, B.; Barr, P.; Lansigan, E.; Cheson, B. D.; Yazdy, M.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Hypertension in ibrutinib-treated patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Roeker, L.; Yazdy, M.; Gashonia, L.; Narkhede, M.; Goodfriend, J.; Rhodes, J.; Kennard, K.; Dorsey, C.; Sarmasti, L.; Calivo, K.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Predicting tumor lysis syndrome in venetoclax-treated CLL patients
    Meeting Abstract

    Roeker, L.; Brander, D.; Coombs, C.; Schuster, S.; Allan, J.; Hill, B.; Lansigan, E.; Cheson, B. D.; Yazdy, M.; Lamanna, N.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Factors impacting treatment selection in treatment-naive patients with CLL: A multicenter study
    Meeting Abstract

    Rhodes, J.; Sail, K.; Yazdy, M.; Hill, B.; Shadman, M.; Tuncer, H. H.; Winter, A.; Kennard, K.; Allan, J.; Ujjani, C.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save